Marc Vogel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Marta Torrens

Parc de Salut

SPAIN

View details

Matthias E. Liechti

Professor

University of Basel

SWITZERLAND

View details

Eva Moore

Clinical Associate Professor

BC Children's Hospital

CANADA

View details

Dzung Vo

Division Head

CANADA

View details

Bartolome Perez-Galvez

Profesor asociado Psiquiatría

Universidad Miguel Hernandez de Elche - Campus San Juan de Alicante

SPAIN

View details

Maree Teesson

AUSTRALIA

View details

Marcus Herdener

University of Zurich

SWITZERLAND

View details

Marc Walter

University of Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marc Vogel

Research Interests

Explore related searches

Contact this professor

Articles (19)

Patient Perspectives on Open-Door Policies in Psychiatry: Mixed Methods Study

Case report: Well-tolerated MDMA-assisted therapy in a 32-year old female patient with advanced alcohol-induced liver cirrhosis

Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial

Diversion of diacetylmorphine in heroin-assisted treatment - a focus group study among patients and treatment providers.

Relative risks of adverse effects across different opioid agonist treatments-A systematic review and meta-analysis.

Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma

Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.

Prolonged diacetylmorphine take-home during the COVID-19 pandemic-Results of a retrospective cohort study.

[Addiction: what's new in 2023].

Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study.

Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial

Buprenorphine Induction: Just a Piece of the Puzzle.

Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.

Striatal resting-state connectivity after long-term diacetylmorphine treatment in opioid-dependent patients.

48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.

Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment.

Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.

Exploring why patients in heroin-assisted treatment are getting incarcerated-a qualitative study.

Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice-Identifying Group Differences and Predictors.

Collaborators (8)

Marta Torrens

Matthias E. Liechti

Eva Moore

Dzung Vo

Bartolome Perez-Galvez

Maree Teesson

Marcus Herdener

Marc Walter

Make your next move.